Skip to main content
Signal8

TripSitter Clinic Ltd. (TSTTF)

TripSitter Clinic Ltd., headquartered in Toronto, Canada, provides a digital healthcare platform operating as a virtual clinic. This service links patients across the United States with qualified physicians who assess their eligibility for a prescribed treatment program utilizing low-dose oral ketamine medication. The platform is designed to assist individuals suffering from a variety of mental health conditions, such as depression, anxiety, post-traumatic stress disorder, bipolar disorder, and obsessive-compulsive disorder. Their comprehensive subscription plan includes initial physician consultations, the provision of oral ketamine prescriptions, facilitated treatment sessions with a licensed medical practitioner, and direct messaging access to that professional. Currently, the company extends its services to clients located in California, Illinois, Arizona, Colorado, Michigan, Washington, Florida, New York, Ohio, and Virginia.

Sector: Medical - Healthcare Information Services

Industry: Medical - Healthcare Information Services

TripSitter Clinic Ltd. logo

TripSitter Clinic Ltd.

OTC:TSTTFHealthcare
Mkt Cap-
EV-
Float6.33M
O/S6.66M
Inst Own-
Net Cash/Sh-$0.04
Dilution
Financials Summary
Revenue$0
Net Income-$7K
Total Assets$837
Free Cash Flow-$33K
Debt & Equity
Total Debt$238K
Total Equity-$523K
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:5Reverse split
    Aug 30, 20235 shares → 1
Balance Sheet Details
Assets$837
Liabilities$524K
Accounts Receivable$0
Accounts Payable$285K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSD
Period Ending2025-01-312024-01-312023-01-312022-01-312021-01-31
Revenue$0$10K$342K$61K$0
YoY Growth--97.1%459.8%--
Cost of Revenue$0$0$245K$449K$0
Gross Profit$0$10K$97K-$388K$0
Gross Margin-100.0%28.4%-635.9%-
Research and Development$0$2K$200K$200K$0
Selling, General, and Administrative$99K$250K$1.27M$1.65M$125K
Other$0$1K$172K-$200K$0
Total Operating Expenses$99K$254K$1.64M$1.65M$125K
Operating Income (EBIT)-$99K-$244K-$1.3M-$1.59M-$124K
Operating Margin--2493.6%-379.3%-2607.5%-
Interest Expense$0$0$0$11.12M$0
Interest Income$0$0$0$0$0
Other Income (Expense)$92K$31K-$6K$0-$811
Income Before Tax (EBT)-$7K-$213K-$1.31M-$7.15M-$125K
Income Tax Expense$0$0$0$0$405
Net Income-$7K-$213K-$1.31M-$7.15M-$126K
Net Income Margin--2181.5%-382.7%-11717.4%-
Supplementary Data
EPS-0.00-0.00-0.03-0.43-0.00
Diluted EPS-0.00-0.00-0.03-0.43-0.00
Weighted Average OS6.66M66.58M60.58M60.58M302.41M
EBITDA-$7K-$244K-$1.3M-$1.59M-$124K
EBITDA Margin--2493.6%-379.3%-2607.5%-
Balance Sheet
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSD
Period Ending2025-01-312024-01-312023-01-312022-01-312021-01-31
Assets
Current Assets
Cash and Cash Equivalents$837$2K$38K$909K$541K
Short-Term Investments$0$0$0$0$0
Cash and Short-Term Investments$837$2K$38K$909K$541K
Accounts Receivable$0$0$11K$42K$6K
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$837$2K$69K$1.02M$546K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0
Goodwill$0$0$0$0$0
Intangible Assets$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0
Total Long-Term Assets$0$0$0$0$0
Other Assets$0$0$0$0$0
Total Assets$837$2K$69K$1.02M$546K
Liabilities
Current Liabilities
Accounts Payable$285K$307K$286K$133K$0
Short-Term Debt$238K$191K$93K$0$13K
Current Income Tax Payable$0$0$0$0$0
Current Unearned Revenue$0$0$0$5K$0
Other Current Liabilities$1K$13K$5K$0$53K
Total Current Liabilities$524$512$384K$138K$65K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$5K$0
Other Liabilities$0$0$0-$5K$0
Total Liabilities$524K$511K$384K$138K$65K
Stockholders' Equity
Preferred Stock$0$0$0$0$0
Common Stock$5.09M$5.09M$5.09M$5.03M$606K
Retained Earnings-$5.78M-$5.8M-$8.59M-$7.28M-$125K
Comprehensive Income & Other-$11K-$4K-$11K-$19K$0
Other Stockholders' Equity$165K$199K$3.18M$3.13M$0
Total Equity-$523K-$509K-$315K$882K$481K
Minority Interest$0$0$0$0$0
Total Liabilities and Equity$837$2K$69K$1.02M$546K
Supplementary Data
Total Debt$238K$191K$93K$93K$13K
Net Debt$237$189K$55K-$815K-$528K
Cash Flow Statement
PeriodFY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSD
Period Ending2025-01-312024-01-312023-01-312022-01-312021-01-31
Operating Activities
Net Income-$7K-$213K-$1.31M-$7.15M-$125K
Depreciation & Amortization$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0
Stock-Based Compensation$0$12K$30K$236K$13K
Changes in Working Capital:
  Accounts Receivable$0$11K$31K$208K-$6K
  Inventory$0$0-$257K-$195K$0
  Accounts Payable$0$42K$226K-$14K$0
  Other Working Capital$40K$21K$302K$130K$53K
Total Working Capital Change$40K$73K$302K$130K$47K
Other Non-Cash Items-$66K-$12K$2K$5.56M$0
Net Cash from Operating-$33K-$141K-$975K-$1.23M-$65K
Investing Activities
Capital Expenditures$0$0$0$0$0
Acquisitions$0$0$0$1.61M$0
Purchases of Investments$0$0$0$0$0
Sales of Investments$0$0$0$0$0
Other Investing Activities$0$0$0$0$0
Net Cash from Investing$0$0$0$1.61M$0
Financing Activities
Debt Repaid---$13K-$13K
Common Stock Issuance$0$0$0$22K$605K
Common Stock Repurchases$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing Activities$0$0$0$2K-$12K
Net Cash from Financing$38K$98K$96K$11K$606K
Forex Effect-$7K$7K$9K-$19K$0
Net Change in Cash-$1K-$36K-$870K$368K$541K
Supplementary Data
Operating Cash Flow-$33K-$141K-$975K-$1.23M-$65K
Capital Expenditure$0$0$0$0$0
Free Cash Flow-$33K-$141K-$975K-$1.23M-$65K
Cash at Beginning$2K$38K$909K$541K$0
Cash at End$837$2K$38K$909K$541K